| Literature DB >> 30976900 |
H Banierink1, I H F Reininga2,3, E Heineman2, K W Wendt2, K Ten Duis2, F F A IJpma2.
Abstract
BACKGROUND: Pelvic ring injuries are serious injuries, often associated with substantial morbidity and mortality rates. The long-term consequences of these injuries might affect the patients' personal life. Our aim was to assess the long-term effects of pelvic ring injuries on physical functioning and quality of life (QoL) using validated patient-reported outcome measures (PROMs) and comparing these results to normative data from the general population. PATIENTS AND METHODS: A retrospective cohort study was conducted on adults treated for pelvic ring injuries between 2007 and 2016. Demographics, fracture type, injury mechanism, treatment and complications were recorded. PROMs questionnaires concerning physical functioning (SMFA) and quality of life (EQ-5D) were used. Patients were divided according to their age (18-30, 31-64, 65 and older) and fracture type (Tile/AO type A, B or C). Differences in SMFA and EQ-5D scores of the operatively and non-operatively treated patients and between the study population and general population were analyzed.Entities:
Keywords: EQ-5D; Functional outcome; Pelvic ring injury; Physical functioning; Quality of life; SMFA
Mesh:
Year: 2019 PMID: 30976900 PMCID: PMC6687880 DOI: 10.1007/s00402-019-03170-2
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 3.067
Fig. 1Flow-chart of patient inclusion for assessment of long-term physical functioning and quality of life after pelvic ring injuries
Individual and injury characteristics of the responders
| Type A ( | Type B ( | Type C ( | All patients ( | |
|---|---|---|---|---|
| Follow-up in years | ||||
| Mean ± std. | 4 ± 2.6 | 4.4 ± 2.6 | 5.2 ± 2.8 | 4.3 ± 2.7 |
| Age (years) at injury | ||||
| Median (range) | 60 (20, 93) | 51 (18, 89) | 38 (19, 62) | 54 (18, 93) |
| Male, | 32 (43) | 60 (61) | 16 (89) | 108 (56) |
| Injury mechanism | ||||
| LET | 38 (51) | 22 (22) | 0 (0) | 60 (31) |
| HET | 37 (49) | 77 (78) | 18 (100) | 132 (69) |
| Treatment | ||||
| Conservative | 71 (95) | 74 (75) | 5 (28) | 150 (78) |
| Operative | 4 (5) | 25 (25) | 13 (72) | 42 (22) |
| ISS | ||||
| Median (range) | 9 (4, 43) | 13 (4, 75) | 21 (11, 43) | 13 (4, 75) |
| ISS ≥ 16, | 29 (39) | 44 (44) | 14 (78) | 87 (45) |
| Highest pelvis AIS | ||||
| Median (range) | 2 (2, 5) | 3 (2, 5) | 3 (2, 4) | 2 (2, 5) |
| AIS 2, | 58 (78) | 43 (43) | 4 (22) | 105 (55) |
| AIS 3, | 16 (21) | 47 (48) | 13 (72) | 76 (39) |
| AIS 4, | 0 (0) | 4 (4) | 1 (6) | 5 (3) |
| AIS 5, | 1 (1) | 5 (5) | 0 (0) | 6 (3) |
LET low-energy trauma, HET high-energy trauma, ISS injury severity score, AIS abbreviated injury score
SMFA-NL and EQ-5D outcomes
| Type A | Type B | Type C | All patients | |
|---|---|---|---|---|
| SMFA | ||||
| Function Index ( | ||||
| Median (range) | 15.4 (0, 92) | 13.6 (0, 83) | 9.0 (0, 51) | 13.9 (0, 92) |
| Mean ± std. | 25.2 ± 27.4 | 20.7 ± 20.7 | 17.5 ± 17.2 | 21.9 ± 22.9 |
| Bother Index ( | ||||
| Median (range) | 19.8 (0, 88) | 14.6 (0, 81) | 16.7 (0, 65) | 16.7 (0, 88) |
| Mean ± std. | 28.8 ± 27.2 | 24.6 ± 23.3 | 22.9 ± 21.6 | 26.1 ± 24.7 |
| Lower extremity ( | ||||
| Median (range) | 13.5 (0, 96) | 10.4 (0, 94) | 11.5 (0, 58) | 12.5 (0, 96) |
| Mean ± std. | 24.3 ± 27.9 | 18.8 ± 22.1 | 17.2 ± 18.4 | 20.5 ± 23.9 |
| Upper extremity ( | ||||
| Median (range) | 0 (0, 96) | 0 (0, 79) | 0 (0, 33) | 0 (0, 96) |
| Mean ± std. | 16.4 ± 26.9 | 9.6 ± 19.6 | 2.3 ± 7.9 | 11.5 ± 22.4 |
| ADL ( | ||||
| Median (range) | 21.3 (0, 96) | 18.6 (0, 90) | 13.1 (0, 65) | 18.8 (0, 96) |
| Mean ± std. | 30.8 ± 31.5 | 26.3 ± 25.1 | 22.2 ± 22.5 | 27.5 ± 27.4 |
| Emotion ( | ||||
| Median (range) | 25 (0, 84) | 21.9 (0, 84) | 18.8 (0, 68.6) | 23.4 (0, 84) |
| Mean ± std. | 29.5 ± 22.3 | 25.9 ± 20.6 | 27.1 ± 21.5 | 27.4 ± 21.3 |
| EQ-5D ( | ||||
| Median (range) | 0.807 (− 0.109, 1) | 0.805 (− 0.134, 1) | 0.843 (0.298, 1) | 0.805 (− 0.134, 1) |
| Mean ± std. | 0.742 ± 0.275 | 0.764 ± 0.264 | 0.792 ± 0.214 | 0.758 ± 0.264 |
ADL activities of daily living
SMFA index scores compared to normative data of the Dutch population
| Patients ( | Fracture typea | Dutch populationa | Difference on a scale from 0 to 100 (%)b | |
|---|---|---|---|---|
| Function | ||||
| Age |
| |||
| 18–30 ( | 16.1 ± 20.1 | 10.1 ± 12.4 | > 0.05 | 6.0 |
| 31–64 ( | 20.7 ± 21.3 | 12.2 ± 13.4 | < | 8.5 |
| ≥ 65 ( | 35.6 ± 35.2 | 12.9 ± 13.5 | < | 22.7 |
|
| ||||
| 18–30 (n = 14) | 17.0 ± 21.0 | 10.1 ± 12.4 | < | 6.9 |
| 31–64 ( | 20.4 ± 19.6 | 12.2 ± 13.4 | < | 8.2 |
| ≥ 65 ( | 23.7 ± 23.3 | 12.9 ± 13.5 | < | 10.8 |
|
| ||||
| 18–30 ( | 11.0 ± 11.8 | 10.1 ± 12.4 | > 0.05 | 0.9 |
| 31–64 ( | 21.4 ± 18.5 | 12.2 ± 13.4 | < | 9.2 |
| Bother | ||||
| Age |
| |||
| 18–30 ( | 17.6 ± 21.6 | 9.0 ± 14.5 | > 0.05 | 8.6 |
| 31–64 ( | 25.1 ± 24.7 | 15.1 ± 18.6 | < | 10.0 |
| ≥ 65 ( | 34.5 ± 29.4 | 15.3 ± 18.7 | < | 19.2 |
|
| ||||
| 18–30 ( | 21.0 ± 25.7 | 9.0 ± 14.5 | < | 12.0 |
| 31–64 ( | 23.8 ± 22.6 | 15.1 ± 18.6 | < | 8.7 |
| ≥ 65 ( | 28.3 ± 23.8 | 15.3 ± 18.7 | < | 13.0 |
|
| ||||
| 18–30 ( | 23.8 ± 22.0 | 9.0 ± 14.5 | < | 14.8 |
| 31–64 ( | 24.5 ± 22.3 | 15.1 ± 18.6 | > 0.05 | 9.4 |
aMean SMFA scores and standard deviation
bDecrease in physical functioning compared to normative data of the Dutch population
SMFA subscale scores compared to the Dutch population normative data
| Patients ( | Fracture typea | Dutch populationa | Difference on a scale from 0 to 100 (%)b | |
|---|---|---|---|---|
| Lower extremity | ||||
| Age |
| |||
| 18–30 ( | 11.7 ± 17.7 | 7.6 ± 12.9 | > 0.05 | 4.1 |
| 31–64 ( | 18.8 ± 21.3 | 10.8 ± 14.4 | < | 8.0 |
| ≥ 65 ( | 36.7 ± 35.0 | 13.6 ± 14.8 | < | 23.1 |
|
| ||||
| 18–30 ( | 15.7 ± 21.6 | 7.6 ± 12.9 | < | 8.1 |
| 31–64 ( | 17.5 ± 20.4 | 10.8 ± 14.4 | < | 6.7 |
| ≥ 65 ( | 23.8 ± 26.1 | 13.6 ± 14.8 | < | 10.2 |
|
| ||||
| 18–30 ( | 13.8 ± 16.2 | 7.6 ± 12.9 | > 0.05 | 6.2 |
| 31–64 ( | 20.1 ± 19.6 | 10.8 ± 14.4 | < | 9.3 |
| Upper extremity | ||||
| Age |
| |||
| 18–30 ( | 9.4 ± 16.5 | 5.5 ± 10.0 | > 0.05 | 3.9 |
| 31–64 ( | 10.1 ± 16.3 | 5.7 ± 11.4 | < | 4.4 |
| ≥ 65 ( | 23.0 ± 33.5 | 7.2 ± 13.8 | < | 15.8 |
|
| ||||
| 18–30 ( | 1.9 ± 5.6 | 5.5 ± 10.0 | > 0.05 | 3.6▲ |
| 31–64 ( | 9.7 ± 20.8 | 5.7 ± 11.4 | < | 4.0 |
| ≥ 65 ( | 13.6 ± 21.1 | 7.2 ± 13.8 | < | 6.4 |
|
| ||||
| 18–30 ( | 0 ± 0 | 5.5 ± 10.0 | > 0.05 | 5.5▲ |
| 31–64 ( | 3.5 ± 9.7 | 5.7 ± 11.4 | > 0.05 | 2.2▲ |
| Daily activities | ||||
| Age |
| |||
| 18–30 ( | 18.6 ± 26.9 | 9.0 ± 14.9 | > 0.05 | 9.6 |
| 31–64 ( | 25.4 ± 27.1 | 14.0 ± 18.1 | < | 11.4 |
| ≥ 65 ( | 40.0 ± 35.3 | 14.0 ± 17.3 | < | 26.0 |
|
| ||||
| 18–30 ( | 21.3 ± 28.4 | 9.0 ± 14.9 | < | 12.3 |
| 31–64 ( | 25.5 ± 23.1 | 14.0 ± 18.1 | < | 11.5 |
| ≥ 65 ( | 30.8 ± 27.9 | 14.0 ± 17.3 | < | 16.8 |
|
| ||||
| 18–30 ( | 15.0 ± 18.0 | 9.0 ± 14.9 | > 0.05 | 6.0 |
| 31–64 ( | 26.9 ± 23.8 | 14.0 ± 18.1 | < | 12.9 |
| Emotion | ||||
| Age |
| |||
| 18–30 ( | 24.3 ± 16.7 | 21.0 ± 16.6 | > 0.05 | 3.3 |
| 31–64 ( | 25.3 ± 20.9 | 22.0 ± 17.7 | > 0.05 | 3.3 |
| ≥ 65 ( | 34.1 ± 24.0 | 19.8 ± 17.1 | < | 14.3 |
|
| ||||
| 18–30 ( | 24.2 ± 25.5 | 21.0 ± 16.6 | > 0.05 | 3.2 |
| 31–64 ( | 26.2 ± 20.8 | 22.0 ± 17.7 | > 0.05 | 4.2 |
| ≥ 65 ( | 26.4 ± 17.9 | 19.8 ± 17.1 | > 0.05 | 6.6 |
|
| ||||
| 18–30 ( | 26.9 ± 20.0 | 21.0 ± 16.6 | > 0.05 | 5.9 |
| 31–64 ( | 29.2 ± 22.7 | 22.0 ± 17.7 | > 0.05 | 7.2 |
aMean SMFA scores and standard deviation
bDecrease in physical functioning compared to normative data of the Dutch population, except for scores indicated with ▲, which indicates the score is higher compared to that of the Dutch population
EQ-5D scores compared to the Dutch population normative data
| Patients ( | Fracture typea | Dutch populationa | Difference on a scale from − 0.329 to 1 (%)b | |
|---|---|---|---|---|
| EQ-5D | ||||
| Age |
| |||
| 18–30 ( | 0.817 ± 0.133 | 0.894 ± 0.154 | > 0.05 | 5.8 |
| 31–64 ( | 0.767 ± 0.241 | 0.853 ± 0.178 | < | 6.5 |
| ≥ 65 ( | 0.712 ± 0.317 | 0.865 ± 0.170 | < | 11.5 |
|
| ||||
| 18–30 ( | 0.781 ± 0.285 | 0.894 ± 0.154 | < | 8.5 |
| 31–64 ( | 0.779 ± 0.255 | 0.853 ± 0.178 | < | 5.6 |
| ≥ 65 ( | 0.733 ± 0.284 | 0.865 ± 0.170 | < | 9.9 |
|
| ||||
| 18–30 ( | 0.766 ± 0.291 | 0.894 ± 0.154 | > 0.05 | 9.6 |
| 31–64 ( | 0.803 ± 0.189 | 0.853 ± 0.178 | > 0.05 | 3.8 |
aMean EQ-5D scores and standard deviation
bDecrease in quality of life compared to the Dutch population
Fracture classification with subtypes according to the AO/OTA method
| All patients (%) ( | |
|---|---|
| 61—A | 184 (45) |
| 61 A1.1 | 2 |
| 61 A1.2 | – |
| 61 A1.3 | 1 |
| 61 A2.1 | 20 |
| 61 A2.2 | 136 |
| 61 A2.3 | 16 |
| 61 A3.1 | 2 |
| 61 A3.2 | 3 |
| 61 A3.3 | 4 |
| 61—B | 174 (42) |
| 61 B1.1 | 10 |
| 61 B1.2 | 11 |
| 61 B2.1 | 104 |
| 61 B2.2 | 9 |
| 61 B2.3 | 7 |
| 61 B3.1 | 5 |
| 61 B3.2 | 5 |
| 61 B3.3 | 23 |
| 61—C | 46 (11) |
| 61 C1.1 | 6 |
| 61 C1.2 | 4 |
| 61 C1.3 | 16 |
| 61 C2.1 | 3 |
| 61 C2.2 | 7 |
| 61 C2.3 | 4 |
| 61 C3.1 | 1 |
| 61 C3.2 | 3 |
| 61 C3.3 | 1 |
| No classificationa, | 9 (2) |
aCould not be classified due to lack of computer tomography imaging